3 charts show how drastically Valeant has changed over the past year (VRX)

Valeant reported mixed earnings Tuesday morning, and the stock is up 13%.
"I am continuously encouraged by the commitment of our employees who work hard daily, rebuilding our relationships with prescribers, patients and payors, and regaining the trust of our debt holders and shareholders," Valeant CEO Joseph Papa said in a release.
The earnings gave an important glimpse into the effects of some of the headlines Valeant's made over the last year. In particular, its product revenue.
Xifaxan
Xifaxa